How to Sell a Dental Practice in 2026: DSO Buyers, Solo Doctor Math, and the EBITDA Multiple Reality

Selling a dental practice in 2026 is fundamentally a choice between two completely different transactions. Path 1: sell to a DSO (Dental Service Organization) for 5-7x EBITDA, with cash + equity + post-close associate compensation, typically requiring 3-5 years of post-close practice as an associate dentist. Path 2: sell to a solo doctor buyer for 60-80% of collections, financed through SBA 7(a), with 6-24 months of seller transition and seller financing 10-25% of purchase price. The choice is not just about price — it’s about post-close life, identity, and tax structure. Most dentists make this decision implicitly by hiring whichever advisor calls them first. That’s a mistake. For a deeper look, see our guide on dental practice valuation calculator.

This guide is for dentists ranging from $500K of collections (small solo practices) to $20M (multi-doctor specialty groups), with normalized earnings between $200K SDE and $5M EBITDA. We’ll walk through the realistic multiples by buyer type and practice size, the DSO vs solo doctor decision framework, the insurance credentialing transfer reality, the chair count / active patient count value drivers, the associate doctor retention dynamics, and the 18-24 month preparation playbook that materially improves outcomes.

The framework draws on direct work with 76+ active U.S. lower middle market buyers and the broader sub-LMM ecosystem. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes major DSOs (Heartland Dental, Pacific Dental Services, Aspen Dental, MB2 Dental, Smile Brands, Specialty Dental Brands and 50+ regional / specialty DSOs), dental-focused PE platforms, family offices with healthcare theses, solo doctor buyers (typically through dental-specific brokers and lenders), and strategic specialty practice consolidators (Ortho2, Specialized Dental Partners, ImageFirst). The point isn’t to convince you to sell — it’s to give you an honest read on what selling a dental practice actually looks like in 2026.

One realistic note before you start. If you’ve heard that “DSOs pay 8-10x EBITDA,” that’s describing platform-quality multi-doctor specialty practices ($2M+ EBITDA, multiple associates, strong specialty mix). The single-doctor general practice doing $1.2M collections and $300K SDE doesn’t play in that range — it sells either to a solo doctor at 60-80% of collections (roughly $720K-$960K), or to a smaller DSO at 4-5.5x EBITDA. Anchor on data for your actual practice profile.

“The single biggest mistake dentists make is not deciding upfront whether they’re selling to a DSO or a solo doctor. The two paths are completely different math, completely different structures, and completely different post-close lives. The right answer is a buy-side partner who already knows which DSOs and solo buyers are actively pursuing your geography this quarter, not a broker selling them a process.”

Key Takeaways

• Two main buyer paths: DSO at 5-7x EBITDA with cash + equity + 3-5 year associate commitment; solo doctor at 60-80% of collections via SBA with 6-24 month transition.
• DSO consolidation is the dominant 2026 dental M&A story. 50+ active DSOs deploying billions annually. Favors $1M+ EBITDA practices with 2,000+ active patients.
• Solo doctor buyers dominate sub-$1M EBITDA. SBA 7(a) financed. Typically pay 60-80% of trailing 12-month collections. Seller financing 10-25%.
• Insurance contract transfer requires re-credentialing buyer doctor (90-180 days per PPO contract). Plan timeline.
• Chair count and active patient count are primary value drivers. 5+ operatories with 2,500+ active patients is the platform sweet spot.
• Associate doctor retention post-close is the gate on DSO earnouts. Lock retention agreements before LOI signed.

DSO buyers vs solo doctor buyers: the two very different math problems

Dental M&A divides cleanly into two buyer-pool worlds, each with completely different math, structures, and post-close implications. Understanding the difference is the single most important decision you’ll make in your sale. DSO buyers underwrite practice EBITDA after a market-rate doctor compensation deduction (typically 25-30% of collections paid to associates). Solo doctor buyers underwrite collections directly because they’ll be the practicing doctor — they think of the deal as buying their job and a practice, not buying a financial asset.

DSO math: 5-7x adjusted EBITDA on $1M+ EBITDA practices. DSOs adjust EBITDA by deducting market-rate associate compensation (typically 25-30% of collections) for the doctor work, then apply 5-7x multiple. On a $3M collections practice with $1.5M owner take-home, the DSO calculation: collections $3M, less production-doctor comp at 28% = $840K, less practice operating costs (front office, hygienists, supplies, lab, rent, etc.) of typically 50-55% of collections = $1.5M-$1.65M. EBITDA = roughly $510K-$660K (vs the $1.5M owner take-home). At 5-7x EBITDA, deal value = $2.5M-$4.6M.

Solo doctor math: 60-80% of trailing 12-month collections. Solo doctor buyers (typically first-time practice owners using SBA 7(a)) pay based on collections rather than EBITDA because they think about the deal as “buying my own future production.” On a $3M collections practice, solo doctor pays $1.8M-$2.4M (60-80% of collections). This is meaningfully less than the DSO purchase price but the post-close life is completely different — the buyer is the practicing dentist, owns the upside of production growth, and owns the practice outright (no equity rollover).

Why DSOs pay more in headline price. DSOs are buying the financial asset (the EBITDA stream) with the expectation that they’ll keep you on as an associate dentist for 3-5 years post-close, generating production at lower cost than your owner-take-home would have implied. They’re also rolling up multiple practices into a platform that they’ll exit at higher multiples in 5-7 years. The headline price is higher, but a meaningful portion of the “value” is delivered through equity in the DSO platform that monetizes only at second exit.

Why solo doctors pay less in headline price. Solo doctors are buying their job and their practice. Their financing capacity is limited by SBA 7(a) caps (typically $5M project size), debt service ratios on their projected production, and personal credit. They can’t pay above what their cash flow can service. The trade-off: simpler structure, faster close, full ownership, no DSO equity dependence, no associate doctor commitment.

How to choose between DSO and solo doctor. DSO is right when: practice is $1M+ EBITDA with multiple associates, you’re willing to practice as associate for 3-5 years post-close, you want second-bite economics through DSO equity rollover, your retirement timeline is 5+ years out. Solo doctor is right when: practice is sub-$1M EBITDA, you want clean exit without 3-5 year commitment, you want full cash certainty without DSO equity exposure, your retirement timeline is 1-2 years out. Many dentists default to DSO without running the solo doctor numbers seriously — that’s often a mistake.

Decision factor	DSO buyer	Solo doctor buyer
Multiple	5-7x adjusted EBITDA	60-80% of trailing 12-mo collections
Cash at close	60-80% of headline price	75-85% of headline price
Equity rollover	20-40% in DSO platform	0%
Post-close commitment	3-5 years as associate	6-24 months transition
Earnout / contingency	Tied to associate retention, EBITDA	Tied to collections continuity
Buyer pool size	50+ active DSOs	100+ solo buyers, broker-channel
Close timeline	120-180 days	90-150 days
Seller financing	Often 0% (DSO funded)	Typically 10-25%

DSO consolidation: who’s actively buying dental practices in 2026

DSO consolidation is the dominant 2026 dental M&A story. Approximately 18-22% of U.S. dental practices are now DSO-affiliated, up from 7% in 2015. The pace of acquisition continues to accelerate. Major DSOs deploy billions of dollars of capital annually, with both general dentistry and specialty (orthodontics, oral surgery, pediatric, endodontics, periodontics) consolidation active.

The major general dentistry DSOs. Heartland Dental (the largest, 1,700+ practices). Pacific Dental Services. Aspen Dental. MB2 Dental (PE-backed, very active). Smile Brands. Western Dental. Affordable Care. Each has specific buy boxes, geographic focus, and integration models. Some prefer general dentistry only; others integrate specialty practices. Some keep selling doctors as long-term associates; others integrate quickly and roll out brand standardization.

The major specialty DSOs. Orthodontics: Smile Doctors, Orthodontic Partners, Specialty Dental Brands, OrthoFX. Oral surgery: U.S. Oral Surgery Management, Oral Surgery Partners. Pediatric: Specialized Pediatric Dental Partners, Lone Peak Dental Group. Endodontics: U.S. Endo Partners, Specialty Dental Brands. Periodontics: U.S. Perio Partners. Each specialty DSO has narrower focus but often pays premium multiples within their specialty (sometimes 7-9x EBITDA for high-quality specialty platforms).

Regional DSOs and emerging consolidators. Beyond the major nationals, 50+ regional DSOs are active in specific geographies (TX, FL, CA, NY, multi-state Southeast, etc.). These regional consolidators often pay slightly lower multiples than nationals but offer more practice autonomy, less brand standardization pressure, and faster close timelines. Many regional DSOs are PE-backed and pursuing specific geographic theses. Worth knowing which regional DSOs are active in your specific market.

What DSOs look for in target practices. Collections of $1M+ for general dentistry, $750K+ for specialty. Adjusted EBITDA of $200K+ as floor, with $500K+ being the platform-eligible target. Active patient count of 1,500+ for general, 800+ for specialty. Multiple operatories (5+ chairs is typical platform threshold). Existing associate doctor or doctor capacity for growth. Strong hygiene production (often 30%+ of total). Geographic fit with DSO footprint. Insurance mix that DSO accepts (most DSOs are heavy PPO; some are willing to convert practices).

Realistic dental practice multiples by structure and size

Dental practice multiples vary by buyer type, practice size, specialty, and geography. Anchor your expectations on the right buyer-type math for your situation. The headlines about “dental practices selling at 8-10x EBITDA” describe specific specialty platforms or multi-doctor practices — not the typical solo general dentistry practice.

Solo doctor buyer multiples (typically SBA-financed). Sub-$500K collections: 50-65% of collections (often 2-2.5x SDE). Practice may struggle to find buyer at all; pool is small. $500K-$1M collections: 60-75% of collections (2.5-3.2x SDE). Core SBA buyer territory. $1M-$2M collections: 65-80% of collections (2.8-3.5x SDE). $2M+ collections sold to solo doctor: rare; typically too large for single-doctor SBA financing. Buyer pool: first-time owner-dentists, often through dental-specific transition brokers.

DSO buyer multiples (general dentistry). $200K-$500K EBITDA: 4-5.5x EBITDA (smaller bolt-on for regional DSOs). $500K-$1M EBITDA: 5-6.5x EBITDA (platform-eligible for many regional DSOs). $1M-$3M EBITDA: 5.5-7x EBITDA (major DSO platform target). $3M+ EBITDA: 6-8x EBITDA with strategic premium for multi-location groups. Specialty practices: typically 0.5-1.5x EBITDA above general dentistry at comparable size.

Specialty practice premiums. Orthodontics: 6-8x EBITDA typical, with high-end ortho-only DSOs paying 7-9x for quality platforms. Oral surgery: 6.5-8.5x EBITDA, with strong demand from specialty-focused PE. Pediatric: 5.5-7.5x EBITDA. Endodontics: 6-8x EBITDA. Periodontics: 5.5-7x EBITDA. The specialty premium reflects scarcity (fewer specialty practices), recurring revenue (orthodontic case treatment plans), and PE platform demand.

Multi-doctor / multi-location practice multiples. 2-3 doctor general practice: 5.5-7x EBITDA. 4+ doctor general practice: 6-8x EBITDA. 2-3 location groups: 6-7.5x EBITDA. 4+ location groups: 6.5-8.5x EBITDA. Multi-doctor / multi-location reduces concentration risk and signals scaling capability, which DSOs value.

Geographic considerations. DSOs concentrate in growing metros (Dallas, Houston, Atlanta, Phoenix, Tampa, Charlotte, Nashville, Austin, etc.) where demographic tailwinds support practice growth. Practices in those markets command 0.5-1x EBITDA premium. Rural practices and slow-growth metros trade at lower multiples even within the same buyer pools because demographic underwriting is weaker.

Practice profile	DSO multiple	Solo doctor multiple	Dominant buyer pool
Sub-$500K collections / $100K EBITDA	4-5x EBITDA (rare)	50-65% of collections	Solo doctor only
$500K-$1M coll / $150-300K EBITDA	5-6x EBITDA (regional DSO)	60-75% of collections	Solo doctor primarily
$1M-$2M coll / $400-700K EBITDA	5-6.5x EBITDA	65-80% of collections	Both DSO and solo
$2M+ coll / $800K+ EBITDA	5.5-7x EBITDA	Rare	DSO primarily
$3M+ coll / $1M+ EBITDA	6-8x EBITDA	N/A	Major DSO, PE platform
Specialty $1M+ EBITDA	6.5-8.5x EBITDA	N/A	Specialty DSO, PE

Insurance credentialing transfer: the 90-180 day mechanic per contract

Insurance credentialing transfer is one of the most underestimated mechanics in dental practice sales. Each PPO contract requires re-credentialing the buyer doctor with the insurance carrier. The credentialing process typically takes 90-180 days per carrier. If your practice has 6-8 PPO contracts (typical for general dentistry in a PPO-heavy market), the buyer faces a 6-12 month overlap during which they’re practicing under your credentials, transitioning to their own, or both.

Why credentialing transfer is structurally important. Most insurance carriers do not allow contracts to simply transfer with the practice in a sale. The new doctor must apply for credentialing in their own name. During the credentialing period, the buyer is technically out-of-network until credentialing completes. Many carriers offer interim provisions or interim billing arrangements, but the patient-facing experience and reimbursement timing can be disrupted. Buyers underwrite this transition disruption when valuing the practice.

How buyers diligence insurance contracts. List of all PPO contracts, fee schedules, and contract dates. PPO mix as percentage of total collections. PPO patients as percentage of active patient base. Average reimbursement as percentage of UCR. Recent fee schedule changes. Pending audits or disputes with carriers. Out-of-network billing patterns. Any fee disputes or claim denials. Understanding which PPOs the buyer wants to maintain vs drop drives deal economics.

Fee-for-service / out-of-network practices: a different valuation profile. Practices that operate primarily out-of-network (fee-for-service or limited-PPO) avoid the credentialing transfer headache. They typically trade at slightly different multiples than PPO practices: lower for general dentistry (because patient base is more mobile and brand-loyalty-dependent on the doctor), higher for cosmetic / implant / specialty (because production per visit is higher, margins are stronger, and the patient base is more affluent / less sensitive to insurance changes). DSO acquirers vary: some prefer FFS practices for higher production per chair; others prefer PPO practices for predictable volume.

What to do 6-12 months before sale. Pull all PPO contracts and document fee schedules. Identify any contracts approaching renewal (some carriers reduce reimbursement at renewal — affects post-close practice economics). Document credentialing timelines per carrier in your geography. If buyer is solo doctor, plan deal close to overlap with credentialing start; if DSO, the DSO often has master credentialing relationships that streamline transfer. The bigger DSOs (Heartland, Pacific Dental, Aspen) have credentialing teams that meaningfully accelerate the process.

Chair count, active patient count, and the operational value drivers

The two primary operational value drivers in dental practice valuation are chair count (operatory count) and active patient count. Chair count caps production capacity. Each operatory chair supports approximately $150-250K of annual production (varies by specialty and practice intensity). Active patient count drives recurring revenue underwriting. Buyers think about the practice as a future production asset, and these two metrics directly determine production potential.

What buyers value in chair count. Total operatories. Active operatories vs. unused. Hygiene operatories vs. doctor operatories (typical practice has 1.5-2x hygiene chairs to doctor chairs). Equipment age in each operatory (digital imaging? digital workflow? CBCT? laser dentistry?). Chair utilization rate during operating hours (under 65% utilization is a flag). Capacity for additional doctors / hygienists. Real estate ownership vs. lease for the operatory space.

What buyers value in active patient count. Active patients (typically defined as patients seen within prior 18-24 months). Total patient files / records. New patient additions per month over 24 months. Patient retention rate. Recall acceptance rate (industry benchmark: 75%+ for healthy practice). Patient demographic mix. Insurance mix of active patients. Average production per active patient per year (industry benchmark: $400-700/year for general dentistry). Geographic concentration of patient base.

The 5-chair / 2,500-patient platform sweet spot. 5+ operatories with 2,500+ active patients is the typical platform threshold for major DSOs. At this size, the practice can support a doctor + 1-2 associates, has meaningful recurring hygiene revenue, has demographic diversification, and supports DSO operating leverage. Below this threshold (3-4 chairs, sub-2,000 patients), the practice is typically seen as a bolt-on for regional DSOs or a target for solo doctor buyers.

Hygiene production: the underrated value driver. Hygiene production typically runs 25-35% of collections in healthy practices. Strong hygiene programs drive recurring revenue (recall visits, prophy, scaling and root planing, periodontal maintenance), which buyers value highly. Hygienist tenure and productivity, recall systems, and hygiene operatory utilization all factor into valuation. Practices with weak hygiene (under 20% of collections) trade at lower multiples because the recurring-revenue story is weaker.

Associate doctor retention: the gate on DSO earnouts

Associate doctor retention post-close is the single biggest operational risk in DSO transactions. If you have associate doctors generating meaningful production at your practice, the DSO is buying their continued production as part of the deal. Associate departure during the first 12-24 months post-close is the most common reason DSO earnouts are clawed back or fail to pay out. Lock down associate retention before LOI signed, not after.

How DSOs structure associate retention. Associate doctors typically need to sign new compensation agreements with the DSO at close, including production-based pay, restrictive covenants (non-compete, non-solicit), and minimum employment commitments. DSOs often offer signing bonuses ($25-150K), equity participation in some cases, and continuing education investment to lock in associate retention. The associate compensation structure post-close is typically less favorable than the pre-close arrangement (production percentages typically lower; benefits more standardized).

What happens if an associate refuses to sign. Practice value drops materially. The lost associate production must be replaced or the deal economics deteriorate. Some DSOs will close the deal with adjusted purchase price; others will walk. The seller is typically blamed for not securing associate retention pre-LOI. Pre-LOI conversations with associates about post-close terms (without disclosing specific buyer until LOI is signed) are critical.

Solo doctor buyer associate retention. Solo doctor buyers typically don’t require associate retention because they’re the new practicing doctor. They may want one of the seller’s associates to stay for 6-12 months as transition support, but they’re not building their deal economics on continued associate production. This is one reason solo doctor sales are often simpler than DSO sales for practices with associate complexity.

What to do 12-18 months before sale. Stabilize associate relationships. Document associate compensation, schedules, and patient panels. Have honest conversations about each associate’s future plans (some associates have been planning their own buyout or relocation that they haven’t shared with you). Identify which associates are critical to deal value vs. replaceable. Consider grooming a successor associate if your current associate has uncertain future plans.

How dental owners should calculate SDE and EBITDA for sale

Dental practice valuation uses both SDE (for solo doctor buyers) and EBITDA (for DSO buyers), with different add-back conventions. Solo doctor buyers think in terms of doctor take-home (SDE less debt service). DSO buyers think in terms of EBITDA after market-rate doctor compensation. Both metrics need to be calculated and presented in the CIM — not just one or the other.

Calculating SDE for solo doctor buyer math. Start with net income from the tax return. Add back interest, taxes, depreciation, amortization. Add owner-doctor’s W-2 salary, owner’s health insurance, family on payroll above market, owner’s discretionary perks (CE travel, conferences with personal benefit, dental association dues). Subtract one-time gains. Add back one-time expenses. The result is SDE — what an owner-dentist takes home from the practice.

Calculating adjusted EBITDA for DSO buyer math. Start with collections. Subtract market-rate doctor compensation for production performed (typically 25-30% of doctor production). Subtract practice operating costs (front office salaries, hygienists, supplies, lab fees, rent, utilities, insurance, marketing, etc.). Subtract owner-replaceable management compensation (typically $80-150K for a practice manager). The result is adjusted EBITDA. DSOs apply 5-7x to this number.

Dental-specific add-backs that buyers will accept. Owner-doctor’s W-2 salary above market for similar role. Spouse on payroll in administrative role. Owner’s health insurance, malpractice insurance, license fees, CE expenses, dental association dues. One-time renovation costs. One-time equipment purchases (CBCT, laser, digital impression scanner) for capability expansion. Excess auto / phone / personal expenses run through the practice. Family member dental work at no charge.

Dental-specific add-backs that buyers will reject. Cash payments not on the books (red flag, signals tax fraud risk). Personal residence rent paid by the practice. Aggressive personal vehicle expenses. Family on payroll above clearly market with no role. Expensive consulting / coaching engagements for the owner’s personal development unless directly tied to practice growth. Personal entertainment that cannot be defended as related to practice.

What dental buyers diligence: the focus areas that determine your final price

Dental practice diligence is more rigorous than many small business categories due to insurance complexity, clinical risk, and regulatory exposure. Buyers focus on financial verification, production trends, insurance contracts, patient base quality, regulatory compliance, equipment condition, and key staff retention. DSO diligence is typically more rigorous than solo doctor diligence due to greater capital deployment and platform integration concerns.

Financial verification. 24-36 months of monthly P&Ls. Tax returns matching financials within 5%. Practice management software reports (Dentrix, Eaglesoft, Open Dental, Curve, etc.) extracted directly. Bank reconciliations. Production reports by doctor and procedure. Collections reports. Adjustments and write-offs. Aging reports. Lab fee analysis. Supply cost analysis.

Production trends and procedure mix. Production by procedure category over 24-36 months. Doctor production split (owner vs. associates). Hygiene production trends. Procedure mix shift (more crowns vs. more endodontics vs. more implants — signals practice direction). New patient additions trends. Treatment plan acceptance rate. Recall completion rate. Cancellation / no-show rates.

Insurance contracts and patient base. Full PPO contract list with fee schedules. PPO mix as percentage of collections. Out-of-network percentage. Average reimbursement as percentage of UCR. Active patient list (typically defined as seen in prior 18-24 months). Patient demographic mix. Insurance mix of patient base. Patient acquisition channel mix (referral, online, insurance directory, etc.).

Regulatory and compliance. State dental board license status. DEA registration. Malpractice insurance history (any claims, settlements). HIPAA compliance documentation. OSHA compliance (sterilization, blood-borne pathogen, hazardous waste). State board complaints history. Recent peer review issues. Sedation permits if applicable. Radiology certifications.

Equipment, technology, and physical plant. Equipment list with age, condition, and replacement schedule. Major equipment (operatory chairs, dental units, sterilization, panoramic / CBCT, laser, intraoral cameras) condition. Practice management software and version. Imaging software. Patient communications platform (Weave, RevenueWell, Solutionreach, etc.). HVAC and plumbing condition. Real estate ownership vs. lease.

Staff retention and key personnel. Hygienist roster with tenure, production, and retention bonuses. Front office staff tenure. Dental assistant / chairside roster. Practice manager tenure and contract terms. Associate doctor agreements. Recent staff departures and reasons. Staff comp benchmarking vs. local market. Staff training programs and certifications.

The dental practice sale process timeline

Dental practice sale processes cluster around 7-10 months for solo doctor sales and 9-13 months for DSO sales. The slightly longer timeline for DSO sales reflects more rigorous QoE diligence, associate retention negotiation, and equity rollover documentation. Insurance credentialing transfer is the longest-running parallel mechanic at 90-180 days per contract.

Months 1-2: positioning and outreach. Build the practice information memo (PIM — the dental industry term for CIM). 20-35 pages typical. Decide DSO vs solo doctor target (or both in parallel). Identify target buyer mix. For DSO: reach out to 8-15 active DSOs in your geography and specialty. For solo: list with dental-specific transition broker or run direct outreach to local doctor buyer pool. Sign NDAs.

Months 2-4: indications of interest and meetings. Take 3-7 buyer meetings or DSO calls. DSOs typically conduct multiple rounds: initial call, full PIM review, regional VP visit, financial diligence interview, leadership meeting. Solo doctor candidates typically visit the practice during operating hours and shadow patient flow. Receive 2-5 indications of interest. Compare DSO offers (which look at adjusted EBITDA) with solo doctor offers (which look at collections).

Months 4-8: LOI, diligence, and parallel processes. Sign LOI with 90-150 day exclusivity. Buyer-side diligence: financial QoE for DSO deals; CPA review for solo doctor; clinical / operational walkthrough; staff interviews; chart review; insurance contract review. Parallel processes: insurance credentialing transfer started; landlord consent if applicable; specific structure negotiation (DSO equity rollover terms, post-close associate compensation, retention bonuses). Buyer financing: DSO has it lined up; solo doctor processes SBA loan (45-90 days).

Months 8-10: definitive agreement and close coordination. Negotiate practice purchase agreement (PPA): purchase price components, working capital target, AR / AP treatment, indemnification, R&W insurance for $2M+ deals, non-compete (typically 5 years and 5-25 mile radius for dental), seller employment agreement (DSO: 3-5 years; solo: 6-24 months). Coordinate close with insurance credentialing milestones, landlord consent, associate retention agreement signing. Final walkthrough. Staff notification (typically 24-72 hours pre-close, with retention bonuses pre-arranged). Patient notification per regulatory requirements.

Months 10+: transition. Post-close transition typically 6-24 months for solo doctor (during which seller doctor sees patients on a part-time basis, transitions referral relationships, and trains buyer on practice systems). Post-close commitment typically 3-5 years for DSO sales (during which seller doctor practices as associate, with production-based compensation, equity vesting, and earnout payments). Insurance credentialing completion 6-12 months post-close. Earnout periods 12-36 months for DSO deals.

Common mistakes dental practice sellers make (and how to avoid them)

Mistake 1: not running DSO and solo doctor scenarios in parallel. Many dentists default to one path without seriously running the numbers on the other. The best practice is to evaluate both scenarios upfront with realistic financial models including post-close compensation, equity outcomes, and tax treatment. Often the math is closer than expected once all factors are considered — and for some sellers, the simpler solo doctor path delivers better lifestyle outcomes even at lower headline price.

Mistake 2: failing to lock associate retention before LOI. Associate retention is the gate on DSO earnouts. Pre-LOI conversations with associates about post-close terms (without disclosing specific buyer until needed) are critical. Associates who walk during diligence cause deal collapse or material price reduction. This is one of the most common avoidable failures in dental M&A.

Mistake 3: under-investing in active patient count maintenance pre-sale. Active patient count typically defined as patients seen in prior 18-24 months drives valuation directly. Practices that allow active patient count to drift down through the 12 months pre-sale (through reduced new patient marketing, weaker recall systems, or owner working fewer hours) see direct multiple compression. The 18-24 month playbook includes maintaining or growing active patient count through to LOI signing.

Mistake 4: hiring a generic business broker instead of dental specialist. Dental M&A is a specialist field. Major DSOs have specific buy boxes that change quarter to quarter. Specialty DSOs (ortho, oral surgery, pediatric) have narrower focus. Solo doctor buyers come through dental-specific channels. A generalist broker who closed a printing company last year doesn’t know which DSOs are active in your geography this quarter.

Mistake 5: ignoring DSO equity rollover analysis. DSO deals typically include 20-40% equity rollover into the DSO platform that monetizes only at second exit (5-7 years). The realized value of this equity depends on DSO platform performance, which most sellers don’t analyze rigorously. Some DSO platforms have delivered exceptional second-exit returns; others have underperformed or held longer than expected. Diligence the DSO’s historical second-exit performance and platform health, not just the headline cash + equity at close.

Mistake 6: announcing the sale to staff too early. Hygienists, dental assistants, and front office staff can fully derail a deal by leaving during diligence. Each key staff departure during LOI is interpreted as instability by buyers. Wait until LOI signed (with retention bonuses for key staff including hygienists with their patient panels), then disclose strategically — usually within 30-60 days of close, with retention bonuses paid at and after close to lock retention through transition.

Tax planning for dental practice exits

Dental practice exits are typically structured as asset sales for solo doctor purchases and stock or hybrid structures for DSO purchases. Asset sales benefit the buyer (depreciation step-up, liability isolation from prior clinical claims) but expose the seller to dual taxation. DSO transactions often use specialized structures (asset purchase + employment + equity rollover) that optimize tax outcomes for both sides.

Typical asset allocation in a $1.5M solo doctor sale. Tangible assets (chairs, equipment, supplies): $200-400K, taxed as ordinary income recapture at up to 37%. Goodwill / intangibles (patient base, practice name, doctor relationships): $900K-$1.2M, capital gains at 15-20%. Non-compete: $50-150K, ordinary income to seller. Consulting / employment agreement: $100-300K, ordinary income spread over agreement period. Allocation negotiation can shift $50-150K of after-tax proceeds in either direction.

DSO transaction tax structure. DSO deals typically use a hybrid structure: cash purchase of practice goodwill at close (capital gains), continuing employment as associate doctor (ordinary income), and equity rollover into DSO platform (potentially tax-deferred under 351 / 721). The mix of cash + employment + equity affects total after-tax proceeds significantly. A skilled tax attorney can shift 5-10% of total deal value through structure optimization.

DSO equity rollover treatment. When you roll 20-40% of equity into a DSO platform (typical), that portion typically receives tax-deferred treatment under Section 351 or 721, depending on the DSO’s entity structure. You don’t pay tax on the rollover until the DSO platform exits in 5-7 years — potentially at a higher multiple. The math on DSO equity rollover has been mixed historically: some DSO second exits have delivered 1.5-2.5x the original rollover value; others have underperformed.

State tax considerations for dental sellers. Wyoming, Texas, Florida, Tennessee, Nevada: 0% state capital gains. California, New York, New Jersey, Oregon: 8-13%+. On a $2.5M dental practice sale, state tax difference can be $200-350K. Some sellers strategically relocate before sale, but real domicile change is required (cosmetic relocations get challenged), and the dental practice itself is geographically tied which complicates planning.

Section 1202 QSBS: typically not available. Most dental practices are LLCs, S-corps, or PCs (professional corporations) and don’t qualify for Section 1202 qualified small business stock treatment. If you’re structured as a C-corp PC and have held the practice 5+ years, talk to a tax attorney 12+ months before sale — QSBS could provide up to $10M of capital gains exclusion. Otherwise, this isn’t an option.

When to wait: signals that delaying 12-24 months pays off

Many dentists would benefit financially from waiting 12-24 months before going to market. At dental practice scale, the leverage from preparation is unusually high. Active patient count growth, hygiene production strengthening, associate retention stabilization, and EBITDA expansion all compound to drive multiple uplift.

Signal 1: active patient count has been declining. If your active patient count declined in the prior 24 months, an 18-24 month rebuilding effort (new patient marketing, recall system improvement, scheduling optimization) typically returns 0.5-1x EBITDA in multiple uplift. Active patient count is the most directly underwritten metric in dental M&A.

Signal 2: you’re within $200K EBITDA of the DSO platform threshold. Crossing $500K EBITDA for regional DSOs or $1M EBITDA for major DSOs widens your buyer pool dramatically. Modest organic growth (8-15% year-over-year is reasonable for healthy dental practices) clears the threshold in 18-24 months. Multiple uplift can be 1-2x EBITDA.

Signal 3: associate doctor situation is unstable. If your associate is shaky / new / planning to leave, stabilizing this 12-18 months pre-sale is critical. DSO buyers will discount or walk on associate-instability. Consider grooming a successor associate or restructuring associate compensation to lock retention before LOI.

Signal 4: hygiene production is below 25% of collections. Strong hygiene programs drive recurring revenue and DSO valuation. 12-24 months of hygiene system improvement (recall protocols, hygiene capacity expansion, prophy / SRP / periodontal maintenance optimization) typically returns 0.5x EBITDA in multiple uplift. Hygiene is the underrated growth lever in dental M&A prep.

Signal 5: insurance contract mix is unfavorable. If you’re heavy in low-paying PPOs (40%+ below UCR), 12-18 months of deliberate fee schedule renegotiation, dropping the worst contracts, or transitioning toward FFS can lift average reimbursement and EBITDA materially. The transition is disruptive in the short term but pays off at exit.

When NOT to wait. Health forcing exit. Co-doctor conflict. Aging out (working capacity declining year over year, which is a personal asset that can’t be rebuilt). Specific market disruption (DSO consolidation slowing in your specialty / geography). Personal financial crisis. In these cases, sell now.

How to position for the right dental buyer archetype

Position for major DSOs when: You have $1M+ EBITDA, multiple operatories (5+), 2,000+ active patients, at least one stable associate doctor, willing to practice as associate for 3-5 years post-close, and want second-bite economics through equity rollover. Emphasize: scalability, recurring hygiene revenue, associate doctor retention, geographic fit with DSO footprint.

Position for regional DSOs when: You have $500K-$1.5M EBITDA, 3-5 operatories, 1,500+ active patients, and want a buyer with more practice autonomy than major nationals provide. Regional DSOs often offer faster close, less brand standardization, and more local market expertise. Emphasize: operational fundamentals, geographic strength, brand value in your local market.

Position for specialty DSOs when: You have a specialty practice (orthodontics, oral surgery, pediatric, endodontics, periodontics) with $400K+ EBITDA and proven specialty volume. Specialty DSOs pay premium multiples within their focus area but only buy in their specialty. Emphasize: specialty production quality, referral relationships, equipment capability, sub-specialty depth.

Position for solo doctor buyers when: Practice is sub-$1M EBITDA, you want clean exit without 3-5 year associate commitment, you’re willing to provide 6-24 months of seller transition and 10-25% seller financing, and your practice runs on documented systems. Emphasize: stability, recurring revenue, manageable transition, clear training path.

Position for dental-focused PE platforms when: You have $2M+ EBITDA multi-doctor or multi-location practice, proven scaling track record, and willingness to roll meaningful equity (25-40%). PE-backed dental platforms often pay competitive multiples to DSOs but with different operating models post-close (less brand standardization, more operational autonomy). Emphasize: scalability, management depth, growth runway.

Conclusion

Selling a dental practice in 2026 is fundamentally a choice between two completely different worlds — DSO economics with cash + equity + 3-5 year associate commitment, or solo doctor economics with cleaner exit and full ownership transfer. The right answer depends on your retirement timeline, your willingness to practice post-close as an associate, your tax situation, and your view on DSO platform second-exit risk. Owners who succeed run both scenarios in parallel before committing, lock down associate retention before LOI, address insurance credentialing transfer proactively, maintain active patient count through to LOI signing, and target the right buyer archetype rather than running a generic listing. The DSO consolidation in dentistry is real and the buyers are sophisticated. The solo doctor buyer pool is deep and the math is cleaner. Both paths can deliver excellent outcomes when prep is done right. Get your books clean. Get your active patient count growing. Get your associate retention locked. Get your hygiene production strong. The dentists who do this work see 30-50% better after-tax outcomes than the ones who go to market unprepared. And if you want to talk to someone who already knows the dental buyers personally instead of running an auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

What multiple should I expect when selling my dental practice in 2026?

Two paths. DSO buyers: 5-7x adjusted EBITDA on $1M+ EBITDA practices, with cash + equity rollover + post-close associate compensation. Solo doctor buyers: 60-80% of trailing 12-month collections, financed through SBA 7(a). Specialty practices command 0.5-1.5x EBITDA premium. Multi-doctor / multi-location practices command additional premium.

Should I sell to a DSO or to a solo doctor buyer?

DSO is right when: practice is $1M+ EBITDA, you’ll practice as associate 3-5 years post-close, you want second-bite economics through equity rollover, retirement is 5+ years out. Solo doctor is right when: practice is sub-$1M EBITDA, you want clean exit, you want full cash without DSO equity exposure, retirement is 1-2 years out. Run both scenarios in parallel before deciding.

Who are the most active DSO buyers in 2026?

Major: Heartland Dental, Pacific Dental Services, Aspen Dental, MB2 Dental, Smile Brands, Western Dental, Affordable Care. Specialty: Smile Doctors, Orthodontic Partners, U.S. Oral Surgery Management, Specialized Pediatric Dental Partners, U.S. Endo Partners, U.S. Perio Partners. Plus 50+ regional DSOs in specific geographies.

How do I handle insurance credentialing transfer?

Each PPO contract requires re-credentialing the buyer doctor (typically 90-180 days per contract). Plan deal timeline accordingly. DSOs often have credentialing teams that streamline transfer; solo doctor buyers must process through each carrier individually. Document all PPO contracts, fee schedules, and patient mix in your PIM.

How much do DSOs really pay vs. what they advertise?

Headline 5-7x EBITDA for $1M+ EBITDA practices is real but understand the structure. Typically: 60-80% cash at close, 20-40% equity rollover (illiquid until DSO second exit in 5-7 years), and 3-5 years of associate compensation post-close at production-based rates. The realized value depends on DSO platform performance, associate compensation post-close, and your practice patterns.

What’s the difference between SDE and EBITDA for a dental practice?

SDE includes the owner-doctor’s full take-home (salary, benefits, personal expenses run through the practice). EBITDA assumes a market-rate doctor compensation deduction (typically 25-30% of doctor production for an associate). Solo doctor buyers underwrite using SDE; DSO buyers underwrite using adjusted EBITDA. Same practice can show $400K SDE and $200K adjusted EBITDA.

How important is associate doctor retention in a DSO sale?

Critical. DSO earnouts are typically tied to associate retention. Associates who walk during diligence or shortly post-close cause deal collapse, price reduction, or earnout claw-back. Lock retention agreements before LOI signed. Pre-LOI conversations with associates about post-close terms are essential.

What’s the role of active patient count in dental practice valuation?

Primary value driver. Active patient count (typically defined as patients seen in prior 18-24 months) drives recurring revenue underwriting and DSO valuation. 2,500+ active patients with 5+ operatories is the typical platform threshold. Maintain or grow active patient count through to LOI signing — declining count compresses multiples directly.

How long does it take to sell a dental practice?

7-10 months for solo doctor sales, 9-13 months for DSO sales. Insurance credentialing transfer adds 6-12 months as a parallel post-close mechanic. Specialty practices and multi-doctor groups typically take longer due to more complex diligence and structure.

What working capital should I expect to leave at close?

Buyers expect normal operating working capital at close: typically 30-60 days of receivables minus payables, plus inventory at normal operating levels. AR treatment in dental sales is variable — some deals include AR in purchase price, others have seller collect AR post-close. Negotiate during LOI.

How much seller financing should I expect to provide?

Solo doctor (SBA-financed) deals: typically 10-25% seller financing as a subordinated note (10-year amortization, 6-9% interest). DSO deals: typically 0% seller note but 20-40% equity rollover instead. The structures are completely different — DSO equity carries platform risk; solo doctor seller note carries buyer credit risk.

Should I run a DSO process or work directly with a buy-side partner?

DSO process via dental-specialist sell-side broker can deliver competitive offers but with 8-12% broker fee and 12-month exclusivity. Direct work with a buy-side partner who already knows the active DSOs and solo doctor buyers in your market avoids the broker fee and exclusivity, often delivers comparable or better outcomes, and runs faster. Worth running both options in parallel for the right size practice.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $200K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — including major DSOs (Heartland Dental, Pacific Dental Services, Aspen Dental, MB2 Dental and others), 50+ regional and specialty DSOs, dental-focused PE platforms, family offices with healthcare mandates, and solo doctor buyers — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-150 days from intro to close) because we already know who the right buyer is rather than running an auction to find one.